Drugs / Alum
last change May 2019 re-read 2 minutes ago

Alum

Developed for
hepatitis B virus infection

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01951677 Comparator Jul 2013 → Oct 2017 hepatitis B virus infection Vaxine Pty Ltd Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Alum ClinicalTrials.gov intervention name — accepted as the source's own label NCT01951677